Balyasny Asset Management
LYEL icon

Balyasny Asset Management’s Lyell Immunopharma LYEL Stock Holding History

Balyasny Asset Management’s Portfolio LYEL Stock Details LYEL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
2024
Q3 		$1.65M Buy
2024
Q2 		$1.43M Buy
2024
Q1 		$528K Buy
2022
Q4 		– Sell
2022
Q3 		$245K Buy
2022
Q2 		– Sell
2022
Q1 		$342K Buy
2021
Q4 		– Sell
2021
Q3 		$1.9M Buy